Dr Wanda Niedbala

  • Honorary Research Fellow (School of Infection & Immunity)

email: Wanda.Niedbala@glasgow.ac.uk

RB430 Level B4, Iii - Gbrc, University Place, Glasgow, G12 8TA

Import to contacts

Publications

List by: Type | Date

Jump to: 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2008 | 2007 | 2006 | 2004 | 2002 | 2001 | 1999 | 1998
Number of items: 20.

2017

Nascimento, D. C. et al. (2017) IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. Nature Communications, 8, 14919. (doi: 10.1038/ncomms14919) (PMID:28374774) (PMCID:PMC5382289)

2015

Besnard, Anne-Gaelle, Guabiraba Brito, Rodrigo, Niedbala, Wanda, Palomo, Jennifer, Reverchon, Flora, Shaw, Tovah N., Couper, Kevin N., Ryffel, Bernhard and Liew, Foo (2015) IL-33-mediated protection against experimental cerebral malaria is linked to induction of Type 2 innate lymphoid cells, M2 macrophages and regulatory T cells. PLoS Pathogens, 11(2), e1004607. (doi: 10.1371/journal.ppat.1004607) (PMID:25659095) (PMCID:PMC4450060)

2014

Barbour, M. et al. (2014) IL-33 attenuates the development of experimental autoimmune uveitis. European Journal of Immunology, 44(11), pp. 3320-3329. (doi: 10.1002/eji.201444671) (PMID:25116404) (PMCID:PMC4449115)

Niedbala, W. et al. (2014) Nitric oxide enhances Th9 cell differentiation and airway inflammation. Nature Communications, 5, (doi: 10.1038/ncomms5575)

2013

Gabriele, L. et al. (2013) Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen. Journal of Allergy and Clinical Immunology, 132(3), 686-695.e7. (doi: 10.1016/j.jaci.2013.02.037)

Niedbala, W., Besnard, A.-G., Jiang, H.-R., Alves-Filho, J.C., Fukada, S.Y., Nascimento, D., Mitani, A., Pushparaj, P., Alqahtani, M.H. and Liew, F.Y. (2013) Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function. Journal of Immunology, 191(1), pp. 164-170. (doi: 10.4049/jimmunol.1202580)

2012

Jiang, H.-R. et al. (2012) IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. European Journal of Immunology, 42(7), pp. 1804-1814. (doi: 10.1002/eji.201141947)

2011

Niedbala, Wanda, Alves-Filho, Jose C., Fukada, Sandra Y., Vieira, Silvio M., Mitani, Akio, Sonego, Fabiane, Mirchandani, Ananda, Nascimento, Daniele C., Cunha, Fernando Q. and Liew, Foo Y. (2011) Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proceedings of the National Academy of Sciences of the United States of America, 108(22), pp. 9220-9225. (doi: 10.1073/pnas.1100667108)

2008

Niedbala, W., Cai, B., Wei, X., Patakas, A., Leung, B. P., McInnes, I. ORCID logoORCID: https://orcid.org/0000-0002-6462-4280 and Liew, F. Y (2008) Interleukin 27 attenuates collagen-induced arthritis. Annals of the Rheumatic Diseases, 67(10), pp. 1474-1479. (doi: 10.1136/ard.2007.083360) (PMID:18199596)

2007

Cai, Beilei, Hueber, Axel J., Leung, Bernard P., Liew, Foo Y., McInnes, Iain B. ORCID logoORCID: https://orcid.org/0000-0002-6462-4280, Niedbala, Wanda and Wei, Xiao-qing (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. European Journal of Immunology, 37(11), pp. 3021-3029. (doi: 10.1002/eji.200737810)

Niedbala, Wanda, Cai, Beilei, Liu, Haiying, Pitman, Nick, Chang, Lynda and Liew, Foo Y. (2007) Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25− T cells via p53, IL-2, and OX40. Proceedings of the National Academy of Sciences of the United States of America, 104(39), pp. 15478-15483. (doi: 10.1073/pnas.0703725104)

2006

Cai, B, Liew, FY and Niedbala, W (2006) Role of nitric oxide in the regulation of T cell functions. Annals of the Rheumatic Diseases, 65, pp. 37-40. (doi: 10.1136/ard.2006.058446)

2004

Wei, XQ, Niedbala, W, Xu, DM, Luo, ZX, Pollock, KGJ and Brewer, JM ORCID logoORCID: https://orcid.org/0000-0001-7933-0915 (2004) Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunology Letters, 94, pp. 35-37. (doi: 10.1016/j.imlet.2004.04.001)

2002

Liew, FY, Niedbala, W and Wei, XQ (2002) IL-15 induces type 1 and type 2 CD4(+) and CD8(+) T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 simulation in vitro. European Journal of Immunology, 32, pp. 341-347.

Niedbala, W, Wei, XQ, Campbell, C, Thomson, D, Komai-Koma, M and Liew, FY (2002) Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor β2 expression via cGMP. Proceedings of the National Academy of Sciences of the United States of America, 99(25), pp. 16186-16191. (doi: 10.1073/pnas.252464599)

2001

Gao, BM, Gracie, JA, Guan, H, Leung, BP, Liew, FY, McInnes, IB ORCID logoORCID: https://orcid.org/0000-0002-6462-4280, Niedbala, W, Orchardson, M, Paterson, GK and Wei, XQ (2001) The sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. Journal of Immunology, 167, pp. 277-282.

Jiang, HR, Wei, X, Niedbala, W, Lumsden, L, Liew, FY and Forrester, JV (2001) IL-18 not required for IRBP peptide-induced EAU: Studies in gene-deficient mice. Investigative Ophthalmology and Visual Science, 42, pp. 177-182.

1999

Niedbala, Wanda, Wei, Xiao-Qing, Piedrafita, David, Xu, Damo and Liew, Foo Yew (1999) Effects of nitric oxide on the induction and differentiation of Th1 cells. European Journal of Immunology, 29(8), pp. 2498-2505. (doi: 10.1002/(SICI)1521-4141(199908)29:08<2498::AID-IMMU2498>3.0.CO;2-M) (PMID:10458764)

1998

Huang, Fang-Ping, Niedbala, Wanda, Wei, Xiao-Qing, Xu, Damo, Feng, Gui-jie, Robinson, John H., Lam, Charles and Liew, Foo Y. (1998) Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. European Journal of Immunology, 28(12), pp. 4062-4070. (doi: 10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K) (PMID:9862342)

Niedbala, W.G. and Stott, D.I. (1998) A comparison of three methods for production of human hybridomas secreting autoantibodies. Hybridoma, 17(3), pp. 299-304.

This list was generated on Tue Jul 1 23:56:53 2025 BST.
Jump to: Articles
Number of items: 20.

Articles

Nascimento, D. C. et al. (2017) IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. Nature Communications, 8, 14919. (doi: 10.1038/ncomms14919) (PMID:28374774) (PMCID:PMC5382289)

Besnard, Anne-Gaelle, Guabiraba Brito, Rodrigo, Niedbala, Wanda, Palomo, Jennifer, Reverchon, Flora, Shaw, Tovah N., Couper, Kevin N., Ryffel, Bernhard and Liew, Foo (2015) IL-33-mediated protection against experimental cerebral malaria is linked to induction of Type 2 innate lymphoid cells, M2 macrophages and regulatory T cells. PLoS Pathogens, 11(2), e1004607. (doi: 10.1371/journal.ppat.1004607) (PMID:25659095) (PMCID:PMC4450060)

Barbour, M. et al. (2014) IL-33 attenuates the development of experimental autoimmune uveitis. European Journal of Immunology, 44(11), pp. 3320-3329. (doi: 10.1002/eji.201444671) (PMID:25116404) (PMCID:PMC4449115)

Niedbala, W. et al. (2014) Nitric oxide enhances Th9 cell differentiation and airway inflammation. Nature Communications, 5, (doi: 10.1038/ncomms5575)

Gabriele, L. et al. (2013) Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen. Journal of Allergy and Clinical Immunology, 132(3), 686-695.e7. (doi: 10.1016/j.jaci.2013.02.037)

Niedbala, W., Besnard, A.-G., Jiang, H.-R., Alves-Filho, J.C., Fukada, S.Y., Nascimento, D., Mitani, A., Pushparaj, P., Alqahtani, M.H. and Liew, F.Y. (2013) Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function. Journal of Immunology, 191(1), pp. 164-170. (doi: 10.4049/jimmunol.1202580)

Jiang, H.-R. et al. (2012) IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. European Journal of Immunology, 42(7), pp. 1804-1814. (doi: 10.1002/eji.201141947)

Niedbala, Wanda, Alves-Filho, Jose C., Fukada, Sandra Y., Vieira, Silvio M., Mitani, Akio, Sonego, Fabiane, Mirchandani, Ananda, Nascimento, Daniele C., Cunha, Fernando Q. and Liew, Foo Y. (2011) Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proceedings of the National Academy of Sciences of the United States of America, 108(22), pp. 9220-9225. (doi: 10.1073/pnas.1100667108)

Niedbala, W., Cai, B., Wei, X., Patakas, A., Leung, B. P., McInnes, I. ORCID logoORCID: https://orcid.org/0000-0002-6462-4280 and Liew, F. Y (2008) Interleukin 27 attenuates collagen-induced arthritis. Annals of the Rheumatic Diseases, 67(10), pp. 1474-1479. (doi: 10.1136/ard.2007.083360) (PMID:18199596)

Cai, Beilei, Hueber, Axel J., Leung, Bernard P., Liew, Foo Y., McInnes, Iain B. ORCID logoORCID: https://orcid.org/0000-0002-6462-4280, Niedbala, Wanda and Wei, Xiao-qing (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. European Journal of Immunology, 37(11), pp. 3021-3029. (doi: 10.1002/eji.200737810)

Niedbala, Wanda, Cai, Beilei, Liu, Haiying, Pitman, Nick, Chang, Lynda and Liew, Foo Y. (2007) Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25− T cells via p53, IL-2, and OX40. Proceedings of the National Academy of Sciences of the United States of America, 104(39), pp. 15478-15483. (doi: 10.1073/pnas.0703725104)

Cai, B, Liew, FY and Niedbala, W (2006) Role of nitric oxide in the regulation of T cell functions. Annals of the Rheumatic Diseases, 65, pp. 37-40. (doi: 10.1136/ard.2006.058446)

Wei, XQ, Niedbala, W, Xu, DM, Luo, ZX, Pollock, KGJ and Brewer, JM ORCID logoORCID: https://orcid.org/0000-0001-7933-0915 (2004) Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunology Letters, 94, pp. 35-37. (doi: 10.1016/j.imlet.2004.04.001)

Liew, FY, Niedbala, W and Wei, XQ (2002) IL-15 induces type 1 and type 2 CD4(+) and CD8(+) T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 simulation in vitro. European Journal of Immunology, 32, pp. 341-347.

Niedbala, W, Wei, XQ, Campbell, C, Thomson, D, Komai-Koma, M and Liew, FY (2002) Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor β2 expression via cGMP. Proceedings of the National Academy of Sciences of the United States of America, 99(25), pp. 16186-16191. (doi: 10.1073/pnas.252464599)

Gao, BM, Gracie, JA, Guan, H, Leung, BP, Liew, FY, McInnes, IB ORCID logoORCID: https://orcid.org/0000-0002-6462-4280, Niedbala, W, Orchardson, M, Paterson, GK and Wei, XQ (2001) The sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. Journal of Immunology, 167, pp. 277-282.

Jiang, HR, Wei, X, Niedbala, W, Lumsden, L, Liew, FY and Forrester, JV (2001) IL-18 not required for IRBP peptide-induced EAU: Studies in gene-deficient mice. Investigative Ophthalmology and Visual Science, 42, pp. 177-182.

Niedbala, Wanda, Wei, Xiao-Qing, Piedrafita, David, Xu, Damo and Liew, Foo Yew (1999) Effects of nitric oxide on the induction and differentiation of Th1 cells. European Journal of Immunology, 29(8), pp. 2498-2505. (doi: 10.1002/(SICI)1521-4141(199908)29:08<2498::AID-IMMU2498>3.0.CO;2-M) (PMID:10458764)

Huang, Fang-Ping, Niedbala, Wanda, Wei, Xiao-Qing, Xu, Damo, Feng, Gui-jie, Robinson, John H., Lam, Charles and Liew, Foo Y. (1998) Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. European Journal of Immunology, 28(12), pp. 4062-4070. (doi: 10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K) (PMID:9862342)

Niedbala, W.G. and Stott, D.I. (1998) A comparison of three methods for production of human hybridomas secreting autoantibodies. Hybridoma, 17(3), pp. 299-304.

This list was generated on Tue Jul 1 23:56:53 2025 BST.